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Laminitis is a common painful condition in horses that often has a poor outcome. The aetiology of laminitis has been 
widely studied, but still not completely understood. There is some evidence that pasture associated laminitis is one 
of the most common forms of laminitis , and this is most likely associated with underlying endocrine dysfunction i.e. 
insulin resistance. However, what the prevalence of insulin resistance in horses presented with laminitis is, that is 
currently unknown and it has not been studied previously.  
 
Endocrinopathic laminitis is a term including laminitis developing subsequently to Equine Cushing’s Disease, equine 
metabolic syndrome and iatrogenic corticosteroid-induced laminitis. The term equine metabolic syndrome includes a 
history of laminitis, insulin resistance and a characteristic phenotype of a cresty neck, bulging supraorbital fat and 
increased fat deposits. Horses suffering from laminitis and insulin resistance seem to have a slow recovery process, 
but recovery is more likely if insulin sensitivity is improved. Increased exercise, maintaining optimal body condition, 
avoidance of high-glycaemic meals and molasses should be incorporated in the treatment of laminitis. Horses with 
insulin resistance have a higher risk of developing laminitis and to find and treat horses with insulin resistance would 
be a means of preventing laminitis. 
 
The purpose of the study was to determine the prevalence of insulin resistance in laminitic horses and ponies in 
Helsinki University Equine Clinic between April 2007 and October 2008. Associations between endocrinopathic 
laminitis and sex, age, body condition score, breed, season, Obel grade, the presence of laminitic rings, cresty neck, 
and bulging supraorbital fat were studied in 50 horses. The associations of the same variables with insulin 
resistance were similarly studied in the 37 laminitic horses. The hypothesis was that a high degree of laminitic 
horses would be insulin resistant and that age, body condition score, breed, season, Obel grade, the presence of 
laminitic rings, cresty neck, and bulging supraorbital fat would be associated with endocrinopathic laminitis.  The 
body condition of the horses was scored using the 0-5 graded Carroll & Huntington body condition scoring. Insulin 
resistance was defined as a basal insulin level of over 30 ?IU/ml. 
 
The prevalence of insulin resistance in these 37 laminitic horses/ponies was 84% (95% CI 69-92%). Bulging 
supraorbital fat, laminitic rings and severe lameness was significantly correlated with endocrinopathic laminitis. The 
mean age of horses with endocrinopathic laminitis was significantly higher than the mean age of horses without 
endocrinopathic laminitis. Laminitic rings were statistically more frequent in horses with insulin resistance and 
laminitis than horses with laminitis and normal insulin level. 
 
The result implies that a high proportion of the horses admitted to the clinic because of laminitis also have insulin 
resistance. The study results justifies including the presence of laminitic rings and bulging supraorbital fat as a 
phenotypic indicators of endocrinopathic laminitis and the equine metabolic syndrome. In this study only basal 
insulin was measured of the horses and it is not the most accurate method of diagnosing insulin resistance. This 
means that some cases of insulin resistance could have been missed. The lack of controls has propably also 
affected the results.  
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Abbreviations 
 
ACTH = Adrenocorticotropic hormone 
BCS = Body condition score 
ECD = Equine Cushing's disease 
EMS = Equine metabolic syndrome 
FSIGT = Insulin-modified frequently sampled intravenous glucose tolerance test 
GLUT1 = Glucose transporter 1 
GLUT4 = Glucose transporter 4  
IL-1 = Interleukin-1  
IL-6 = Interleukin-6  
ITT = Insulin tolerance test 
MIRG = The modified insulin response to glucose  
OGTT = Oral glucose tolerance test  
PPID = Pituitary pars intermedia dysfunction 
RISQI = The reciprocal of the insulin square root index 
TNF-? = Tumour necrosis factor ?  
?IU = micro international unit 
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1 LITERATURE REVIEW 
  
1.1 Structure and effect of insulin  
 
Insulin is a peptide hormone produced by the pancreatic ?-cells as a preprohormone, 
which is converted to proinsulin. Proinsulin is converted to biologically active insulin 
immediately before secretion. Insulin release is dose dependent on glucose ingestion 
(Waldhausl, 1989). Increase in serum concentrations of amino acids also stimulates 
insulin secretion. Hormonal regulation of ?-cells is mediated by glucagon stimulating the 
?-cells and somatostatin inhibiting the ?-cells. The nervous system also regulates insulin 
secretion: the sympathetic system inhibits it and the parasympathetic system stimulates it. 
Glucocorticoids have insulin-antagonist effects and catecholamines inhibit glucose-
stimulated insulin secretion (Masuzaki et al. 2001). 
 
The primary action of insulin is to stimulate cell uptake and metabolism of nutrients, 
mainly glucose. Insulin binds to cellular membrane receptors that act as a tyrasine kinases 
and consequently phosphorylation of intracellular proteins occurs (Saltiel & Kahn, 2001). 
For the regulation of glucose transport into the cell, insulin recruits glucose transport 
molecules 4 (GLUT4) to the cell membrane. Insulin stimulates glucose uptake in nearly 
all tissues, but particularly in skeletal muscles and adipose tissue (Saltiel & Kahn, 2001). 
Glucose uptake is via glucose transport molecules (GLUT1) is insulin independent 
(Saltiel & Kahn, 2001). The brain, the liver, the intestinal, kidney and mammary 
epithelial cells are to a great extent independent of insulin for their glucose requirements 
(Sjaastad et al. ). Insulin also regulates fat metabolism, vascular function, inflammation, 
tissue remodelling and the somatotropic axis of growth. Insulin inhibits the production 
and release of glucose from the liver (Saltiel & Kahn, 2001). 
 
A circadian rhythm of insulin secretion has been demonstrated in normal horses (Evans et 
al. 1974). Insulin is influenced by exercise, decreasing after exercise and then returning to 
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increased concentrations after 30 minutes (Freestone et al. 1991). These fluctuations are 
however always within the normal range in a normal, healthy individual. 
 
 
1.2 Insulin resistance 
 
Insulin resistance is the inability of normal insulin concentrations to elicit a normal 
physiological response. The tissues responsiveness to insulin is decreased and the horse 
has to rely on the glucose-mediated disposal of glucose that happens independently of 
insulin (Hoffman et al. 2003). The reason for insulin resistance can be at the level of the 
insulin receptor or it can be subsequent to insulin binding to the insulin receptor (a post 
receptor effect). The insulin receptor can be down regulated as a consequence of long 
lasting hyperglycaemia and hyperlipaemia. Inadequate response to hormonal signalling 
despite normal insulin binding to the receptor can be caused by disruption of the glucose 
uptake pathways (Treiber, Kronfeld and Geor 2006, Kronfeld et al. 2005). Most horses 
are able to compensate for the insulin resistance in tissues by increased release of insulin 
from the pancreatic ?-cells and the blood glucose remains within normal limits.  For 
biologic action to occur a number of receptors have to be occupied and if most receptors 
are non-functional the body responds by increasing insulin release. With 
hyperinsulinaemia insulin action in certain resistant pathways is decreased, while in other 
unaffected pathways insulin signalling is increased. Secondary failure to secrete insulin, 
with pancreatic exhaustion following decreasing tissue insulin resistance, rarely occurs in 
horses. This kind of uncompensated insulin resistance has been demonstrated in a pony 
using the frequent sampling intravenous glucose tolerance test (Hess et al. 2006). 
 
1.2.1 Factors influencing insulin sensitivity 
 
Factors influencing insulin sensitivity include age, breed, pregnancy, lactation, 
inflammation, obesity, fasting, starch versus fat content of concentrates, training, 
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supplements and drugs, such as chromium, metformin, levothyroxine, corticosteroids and 
xylazine (Firshmann & Valberg, 2007). 
 
Fetal foals have comparatively low levels of serum insulin and maturation of pancreatic 
?-cell function occurs over time. The rate of acquired insulin resistance with increasing 
age in mature horses is dependent upon environment, diet and genetic factors (Firshmann 
& Valberg, 2007, Murphy et al. 1997). 
 
Temporary physiologic insulin resistance can occur due to inflammatory conditions, 
infections, injury, starvation, pregnancy and puberty (Firshmann & Valberg, 2007, 
Fowdean et al. 1984). Insulin resistance is also thought to be involved in pathologic 
conditions, such as obesity, uraemia, cortisol excess or growth hormone excess 
(Firshmann & Valberg, 2007). Insulin resistance has been associated with laminitis and 
obesity (Johnson & Ganjam, 1999, Hoffman et al. 2003). It has been shown to be a risk 
factor for laminitis and obesity has been shown to be a risk factor for insulin resistance 
(Johnson & Ganjam, 1999, Hoffman et al. 2003). In the pre-pubertal patient, insulin 
resistance has been associated with osteochondritis dissecans lesions (Ralston, 1995). It is 
also thought to be involved in the pathogenesis of pars intermedia dysfunction (Frank et 
al. 2006), hyperlipaemia, and equine metabolic syndrome (Johnson, 2002). Exertional 
rhabdomyelisis on the contrary is associated with increased insulin sensitivity (Annandale 
et al. 2004). 
 
Glucocorticoids oppose insulin actions by promoting gluconeogenesis in the liver and 
inhibit glucose uptake in the peripheral tissues. A seven day dexamethasone 
administration showed evidence of insulin resistance and increased pancreatic insulin 
response compared to a control group (Tiley et al. 2007).  Xylazine (?-adrenoreceptor 
antagonist) inhibits insulin release from pancreatic ?-cells and results in hyperglycaemia, 
which has to be taken into account when evaluating blood samples taken from horses 
sedated with xylazine (Greene et al. 1987). 
 
 7
1.2.2 Diagnosis of insulin resistance 
 
Current techniques to diagnose insulin intolerance in horses include the basal glucose and 
insulin measurements, oral glucose tolerance test (OGTT), insulin-modified frequently 
sampled intravenous glucose tolerance test (FSIGT), insulin tolerance test (ITT), 
hyperglycaemic and the euglycaemic clamp techniques and the minimal model of glucose 
and insulin dynamics (Pratt et al. 2005). The hyperglycaemic and euglycaemic clamp 
techniques were developed for diagnosing insulin resistance in humans, but they have 
been shown to be useful in horses (Rijnen et al. 2003). 
The hyperglycaemic/euglycaemic clamp techniques and the insulin-modified frequently 
sampled intravenous glucose tolerance test with minimal model analysis are the most 
accurate methods. Proxy measurements (the reciprocal of the insulin square root index 
RISQI, the modified insulin response to glucose MIRG) calculated from serum basal 
insulin have been shown to be predictive (Kronfeld et al. 2005, Kronfeld 2006). RISQI is 
a proxy used for calculating insulin sensitivity (the capacity of insulin to cause glucose 
disposal) and MIRG is a proxy used to calculate the pancreatic ?-cell response. Glucose 
effectiveness (the capacity of glucose to mediate its own disposal independent of plasma 
insulin) can also be calculated.  
 
Basal values of glucose and insulin represent an end-point reached after considerable 
regulation, but they provide an example of the current chronic state of the patient. There 
are also potentially large fluctuations in a 24 hour period of the basal insulin level in 
horses and a single measurement of the patient's basal insulin may not be representative 
(Evans et al. 1974).  They are, however, the most practical test for insulin resistance and 
insulin response for screening purposes (Kronfeld et al. 2005, Treiber, Kronfeld and Geor 
2006, Walsh et al. 2008). Geor and Harris (2009) suggested the following sampling 
protocol for measurement of the basal insulin: all feed should be withheld for a minimum 
of 8 hours before sampling and  blood should be drawn between 7:00 and 10:00 am. 
Removal from pasture before sampling is recommended. In laminitic horses, testing 
should be delayed until after resolution of the acute laminitic episode, because the 
associated pain and stress can exacerbate hyperinsulinemia (Geor and Harris, 2009). 
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1.2.3 Pathogenesis of insulin resistance 
 
The equine metabolic syndrome, including insulin resistance and laminitis, has been 
studied in a closed herd of ponies and the syndrome seems to be at least partly hereditary 
(Treiber, Kronfeld, Hess et al. 2006). In natural conditions with unreliable food supply, 
insulin resistance in the muscle would have been an advantage for survival. Insulin 
resistance could be a metabolic adaptation in these certain breeds (Treiber, Kronfeld, 
Hess et al. 2006). Beside pony breeds Morgan horses, domesticated Spanish mustangs, 
European Warmbloods and American Saddlebreds have been implicated to have a higher 
risk for developing insulin resistance (Johnson et al. 2004). 
 
During pregnancy mares exhibit higher levels of insulin after exogenous and endogenous 
glucose increase, because of an enhanced ?-cell response to glucose. Glucose is not taken 
up by maternal tissues, in which the insulin sensitivity is reduced, but redirected to 
nourish the fetus. After 270 days of gestation there’s a fall in the insulin concentration, 
most likely due to exhaustion of the ?-cells (Fowdean et al. 1984). 
 
Obesity, inflammatory cytokines and insulin resistance are interrelated (Vick et al. 2007). 
Insulin sensitivity was reduced in obese compared to non obese geldings, with insulin 
sensitivity estimated with a minimal model analysis (Hoffmann et al. 2003). In humans 
and rats obesity resembles an inflammatory state, with increased acute phase proteins and 
inflammatory cytokines (Tilg and Moschen, 2008). Adipocytes are capable of secreting 
endocrine signals that cause insulin resistance. Leptin acts as an endocrine signalling 
molecule affecting hunger, it is secreted by adipose tissue and its concentrations are 
significantly higher in ponies with insulin resistance (Van Weyenberg et al, 2007). 
Omental adipocytes also contain an enzyme (11-? hydroxysteroid dehydrogenase) that 
converts inactive cortisone to active cortisol (Masuzaki et al. 2001). Cortisol opposes 
insulin activity in carbohydrate metabolism, causing decreased glucose uptake in 
peripheral tissues and increased hepatic glucose production (Masuzaki et al. 2001). 
Weight loss by energy restriction on the other hand improved insulin sensitivity in obese 
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ponies (Van Weyenberg et al, 2008). Insulin resistance developed after adult mares were 
subjected to a systemic inflammation induced by lipopolysaccharide. During this induced 
inflammatory state the adipose tissue responded with an upregulation in mRNA 
expression of the inflammatory cytokines interleukin-1 (IL-1), interleukin-6 (IL-6) and 
tumour necrosis factor ? (TNF-?) (Vick et al. 2008). 
 
Even relatively short periods of fasting have caused insulin resistance in horses (Treiber 
et al. 2005, Hoffmann et al. 2003). The composition of the diet also affect the insulin 
sensitivity in horses, as horses fed meals high in starch and sugar have an increased risk 
of developing insulin resistance compared to horses fed meals with a higher content of fat 
and fibre. In ponies predisposed to laminitis insulin concentrations increased significantly 
after addition of fructan carbohydrates to the diet (Bailey et al. 2007). Fructan 
carbohydrates are storage carbohydrates found in some grasses and have been implicated 
in the pathogenesis of laminitis. The study indicates that fructans could be a factor in the 
development of insulin resistance in laminitis prone ponies at pasture (Bailey et al. 2007).  
Increased plasma triglyceride concentrations in nonobese laminitis-prone ponies, may 
indicate an underlying dyslipidemia associated with insulin resistance (Bailey et al. 
2008). 
 
1.2.4 Treatment of insulin resistance 
 
Methods to improve insulin sensitivity in horses include increased exercise, maintaining 
optimal body condition and avoidance of high-glycaemic meals and molasses. 
Agents that counter insulin resistance, for example cinnamon, thiazolidinediones or 
biguanides, may improve peripheral glucose uptake (Harris et al. 2006). These agents 
need to be examined for effectiveness in a clinical situation (Harris et al. 2006). 
Levothyroxine decreases blood lipid concentrations and body weight, and improves 
insulin sensitivity (Ralston, 2002). Metformin is a biguanide drug used in human 
medicine to increase insulin sensitivity. Metformin improved insulin sensitivity and 
decreased pancreatic ?-cell secretion of insulin significantly in a study of 18 horses, 
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although the short-term response (6-14 days) was more favourable than the long-term 
(23-220 days) (Durham et al. 2008).  
 
Exercise increases glucose uptake in skeletal muscle and thus increases insulin sensitivity 
as skeletal muscle is the principal site for insulin mediated glucose disposal and therefore 
also the major site of peripheral insulin resistance. Hyperinsulinaemic obese ponies had 
improved insulin sensitivity after 2 weeks of increased training (Ralston, 2002). In a 
study by Pratt et al. (2006) physical conditioning lessened the decrease in insulin 
sensitivity caused by a diet high in non structural carbohydrates in normal Standard bred 
horses.  
 
 
1.3 Laminitis 
 
Laminitis is a common, painful condition in horses. It is broadly defined as an 
inflammation of the laminae leading to a degeneration of the primary and secondary 
laminae of the equine hoof. As a consequence the space between the hoof wall and the 
coffin bone widens which results in a chronic instability of the hoof.  
 
Laminitis can be categorized as acute, subacute or chronic. In acute laminitis there is an 
acute onset of lameness in one or more limbs, an increased digital pulse and an increase 
in the temperature of the hoof occurring for less than 72 hours. The pain causes a 
characteristic wide base stance, inability to lift the hooves and in the worst cases, inability 
to stand. In acute laminitis the distal phalanx is not displaced. In subacute laminitis the 
horse shows the same clinical signs as in acute laminitis, except the duration is longer 
than 72 hours. Horses with chronic laminitis show the signs of chronic pain and lameness 
and the hoof walls may exhibit laminitic rings. Radiographically the changes in chronic 
laminitis can be seen as rotation and sinking of the coffin bone, a point at the tip of the 
coffin bone and a darkened line between the hoof wall and the coffin bone. 
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The lameness in laminitis can be graded using the Obel grading system (Obel, 1948). 
Obel Grade 1 is when a horse shows frequent shifting of weight between the feet, but no 
visible lameness at the walk, and bilateral lameness when trotting. Obel Grade 2 is when 
a horse does not resist having a foreleg lifted, nor to walk, but it does show lameness at 
the walk. Obel Grade 3 horses object to the foreleg being lifted, and are reluctant to walk. 
An Obel Grade 4 horse will only walk if it is forced to. 
 
Age, sex, breed, seasonality, obesity, insulin resistance, gut disturbance and 
endotoxaemia are known risk factors for developing laminitis (Polzer & Slater, 1996, 
Alford et al. 2001, Snook Parsons et al. 2007). Age, breed and seasonality were not 
shown to be statistically significant risk factors for acute laminitis, but age and 
seasonality were statistically significant risk factors for chronic laminitis (Polzer & Slater, 
1996). Obesity and a cresty neck seem to be a risk factor for both acute and chronic 
laminitis. Mares had a higher risk to develop laminitis than geldings and ponies are 
generally more prone to develop laminitis than horses (Alford et al. 2001). 
 
The aetiology of equine laminitis is still unknown. Most research has focused on 
inflammatory laminitis associated with severe systemic inflammation secondary to 
gastrointestinal disease, especially the carbohydrate overload model, oligofructose 
overload model and the Black Walnut toxicity model. Overfeeding of cereals (Obel, 
1948) lush pasture, bolus feeding of oligofructose (French & Pollitt, 2004) and black 
walnut extract (Eaton et al. 1995) can reproducibly cause laminitis. Theories on the 
pathogenic/aetiologic mechanisms of these forms of laminitis include: 1) disruption in the 
vascularization due to increased venous resistance leading to a period of ischaemia, 
followed by reperfusion injury, 2) haematogenous spread of inflammatory, toxic, 
metabolic or enzymatic trigger factors or 3) trauma to vascular endothelium or peripheral 
nerves resulting in blood pooling in the hoof. Lately, studies have focused on finding 
trigger factors involved in inflammatory states, which cause vasoconstriction and 
decreased vascularization, thus combining the theories of disruption of vascularization 
and inflammatory trigger factors. Trigger factors studied include matrix metalloproteinase 
enzymes, nitric oxide, 5-hydroxy-tryptamine, cyclo-oxygenase and interleukin (Bailey et 
al. 2004). 
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There has been less research on the pathogenesis of endocrine laminitis. However, the 
general mechanisms explored included glucose deprivation and hyperinsulinaemia. Hoof 
tissue has a high demand of glucose and it uses glucose at much faster rate than other 
tissues (Wattle & Pollitt, 2004). Glucose deprivation was shown in vitro to result in 
separation of connective tissue between coffin bone and hoof (Pass et al. 1998).  
 
 
1.4 Relationship between insulin resistance and laminitis 
 
Insulin resistance was suggested to play a role in the pathogenesis of laminitis for the first 
time in the 1980’s. A relative glucose intolerance and resistance to exogenous insulin was 
found in ponies, with a history of laminitis, compared to ponies with no history of 
laminitis (Jeffcott et al. 1986, Coffman & Colles, 1983). In 1985 Jeffcott and Field 
demonstrated diminished oral glucose tolerance and intravenous insulin tolerance in 
obese and laminitic ponies compared to normal Standardbred horses. Their theory was 
that the ponies had a clinical condition with stress and insulin intolerance associated 
hyperlipaemia and laminitis. This would be due to an innate peripheral insensitivity to 
insulin in ponies, causing poorly regulated mobilization of fatty acids (Field & Jeffcott, 
1989). This metabolic state may be manifested seasonally, possibly linked to the nutrients 
in pastures (Bailey et al. 2008). Plasma insulin concentrations were significantly 
correlated to laminitis grade and a decrease in plasma insulin concentration was 
significantly correlated to a decrease in laminitis grade in a study by Walsh et al. (Walsh 
et al. 2009). 
 
The term equine metabolic syndrome (EMS, insulin resistance syndrome) was first used 
by Johnson in 2002, before that the syndrome had been described by Johnson and Ganjam 
in 1999 and named a peripheral cushingoid syndrome.  The syndrome includes a history 
of laminitis, insulin resistance and a characteristic phenotype of a cresty neck, bulging 
supraorbital fat and increased fat deposits in the withers and the dorsal back (Johnson, 
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2002). Especially a cresty neck score and a high body condition score serve as phenotypic 
indicators associated with insulin resistance (Walsh et al. 2008, Frank et al. 2006). 
 
There are three main theories of the mechanisms by which insulin resistance would cause 
laminitis. The first theory is that the connection lies in impairment of glucose uptake, the 
second in vascular effects caused in the hoof and the third in pro-inflammatory effects 
caused by inflammatory agents (Bailey et al. 2008, Vick et al. 2008). 
 
Impaired glucose uptake by lamellar epithelial cells, the first theory, has been suggested 
as a possible link between insulin resistance and laminitis (Bailey et al. 2008). As 
mentioned before, the high demand of glucose and fast rate of glucose use of the hoof 
tissue, because of the lack of tissue with glycogen storage capacity in the hoof, could 
implicate that glucose deprivation could be a factor in the laminitis aetiology (Wattle & 
Pollitt, 2004). When hoof tissue was subjected to glucose deprivation in vitro, it resulted 
in separation of connective tissue between coffin bone and hoof (Pass et al.1998). 
However, in a later study glucose uptake to hoof lamellae were shown in vitro to happen 
via glucose transporter molecules 1 (GLUT1) that are independent of insulin and not via 
insulin dependent glucose transporter molecules 4 (GLUT4) (Asplin, McGowan et al. 
2007, Wattle & Pollitt, 2004). 
 
Endothelial dysfunction, the second theory, may be a cause for the increased risk of 
developing laminitis in insulin resistant ponies, as endothelial dysfunction would cause 
vasoconstriction and hypertension. Ponies with recurrent laminitis have previously been 
found to be hypertensive compared to control ponies (Bailey et al. 2008). Glucocorticoids 
and catecholamines are elevated during the endotoxaemic phase of the carbohydrate 
overload. Glucocorticoids may potentate the vasoconstrictive action of catecholamine and 
cause laminitis by reducing blood flow through lamellar connective tissues (Johnson & 
Ganjam, 1999).  
 
Obesity, inflammatory cytokines and insulin sensitivity has been shown to be interrelated 
and this could be the third possible connection between laminitis and insulin resistance. 
Obesity in association with tissue resistance to insulin could cause an inflammatory state 
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in the patient. This inflammatory state, with the release of inflammatory cytokines, could 
predispose to laminitis. The inflammatory cytokines TNF-?, TNF-?-protein, IL-1 and IL-
6 have been found in increased numbers in obese ponies (Vick et al. 2007, Vick et al. 
2008).  
 
When prolonged hyperinsulinaemia was caused in clinically normal ponies they all 
developed laminitis in all four hooves (Asplin, Sillence et al. 2007). As none of the 
ponies had insulin resistance and their blood glucose was maintained within normal 
values, the conclusion was that prolonged hyperinsulinaemia induces laminitis 
independent of changes in blood glucose concentration or insulin sensitivity.  
 
Equine Cushing’s disease (ECD, Pituitary pars intermedia dysfunction) is a disease 
caused by loss of tonic inhibition by dopamine of the pars intermedia of the pituitary 
gland (Schott, 2002). This causes a markedly increased adrenocorticotropic hormone-
level (ACTH) and the clinical signs are mainly attributed to its effects. The clinical signs 
are changes in fat distribution (pot belly, muscle wasting and bulging supraorbital fat), 
polyuria and polydipsia, susceptibility to infections and laminitis (Schott, 2002). Equine 
Cushing’s disease is frequently associated with both insulin resistance and laminitis 
(Keen et al. 2004). Insulin resistance could be a cause of increased levels of 
glucocorticoids in ECD, but it is also likely that many horses are genetically affected with 
insulin resistance and later develop Equine Cushing’s disease (Johnson, 2002). Although 
there is a clear relationship between EMS and ECD, they are two different syndromes as 
EMS horses have been tested negative for ECD (Reeves et al. 2001). Measuring the basal 
insulin value in diagnosed ECD cases has been proved to be of prognostic value. Horses 
with a marked hyperinsulinaemia have a poorer prognosis than those with a normal or 
mildly increased basal insulin value (McGowan et al. 2004). Basal serum insulin has also 
been used as a diagnostic indicator of ECD, but research has indicated that it is not a 
specific indicator of the disease (Reeves et al. 2001). Laminitis occurring subsequently to 
changes in the hormonal status of the horse has been defined as endocrinopathic laminitis 
(Johnson, 2004). This includes laminitis developing subsequently to ECD, EMS and 
iatrogenic corticosteroid-induced laminitis. Insulin has been shown to be the final 
triggering event in the development of endocrinopathic laminitis (Asplin, Sillence et al. 
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2007). The induction of laminitis in this study happened independently of diet and 
gastrointestinal disturbances. In the study the horses were subjected to high levels of 
insulin, so whether long-term exposure to lower insulin levels would cause the same 
effect still needs to be established. 
 
The significance of the connection between laminitis and insulin resistance is the 
possibility of determining the risk of laminitis in the patient and reducing this risk. 
Endocrinopathic laminitis seems to have a slow recovery process and an ideal clinical 
outcome is more likely if hyperinsulinaemia is reversed early in the process (Walsh et al. 
2008). Baseline concentration of plasma insulin is a useful tool for predicting the risk of 
laminitis to occur and also for predicting prognosis of laminitis. Plasma leptin 
concentrations could also be useful for predicting total fat mass and diagnosing insulin 
resistance in ponies, because of the high correlation with insulin resistance (Van 
Weyenberg et al. 2007). 
 
Factors influencing insulin resistance and the connections between insulin resistance, 
laminitis and ECD are collected into figure 1. 
 
Methods to improve insulin sensitivity in horses, such as increased exercise, maintaining 
optimal body condition, weight loss in obese horses, avoidance of high-glycaemic meals 
and molasses could also reduce the risk of laminitis and the clinical signs of laminitis. 
The diet should be based on mature grass hay, with supplements of vitamins and 
minerals. Grains and sweet feeds as well as pasture should be avoided. (Geor and Harris, 
2009). Agents that counteract insulin resistance could also become a part of the treatment 
of laminitis. 
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Figure 1. Causality of risk factors for laminitis and insulin resistance and associations 
between insulin resistance, laminitis and Equine Cushing’s Disease (ECD) as composed 
by the author. 
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2 ENDOCRINOPATHIC LAMINITIS IN EQUINE CLINIC 
PATIENTS IN FINLAND 
 
2.1 Introduction 
 
Laminitis is a common painful condition in horses that often has a poor outcome. The 
painfulness, poor prognosis and frequency of occurrence of the disease make it important 
both in an animal welfare and economical point of view. The aetiology of laminitis has 
been widely studied, but still not completely understood. 
  
The association between insulin resistance and laminitis has been demonstrated in 
multiple studies (Jeffcott et al. 1986, Coffman & Colles, 1983, Bailey et al. 2008, Field & 
Jeffcott, 1989). Plasma insulin concentrations were significantly correlated to laminitis 
grade and a decrease in plasma insulin concentration was significantly correlated to a 
decrease in laminitis grade in a study by Walsh et al. (2009). Prolonged 
hyperinsulinaemia caused laminitis in horses in a study by Asplin et al (2007). 
 
Endocrinopathic laminitis is a term including laminitis developing subsequently to 
Equine Cushing’s Disease, equine metabolic syndrome and iatrogenic corticosteroid-
induced laminitis (McGowan, 2008). The term equine metabolic syndrome (EMS, insulin 
resistance syndrome) was first used by Johnson in 2002. The syndrome includes a history 
of laminitis, insulin resistance and a characteristic phenotype of a cresty neck, bulging 
supraorbital fat and increased fat deposits in the withers and the dorsal back (Johnson, 
2002). A cresty neck and a high body condition score can serve as phenotypic indicators 
associated with insulin resistance (Walsh et al. 2009, Frank et al. 2006).  
 
The reasons for separating endocrinopathic laminitis as an entity of its own as opposed to 
laminitis developing of other causes are the poorer prognosis, the importance of exercise 
and diet in the treatment, the phenotypic indicators and the strong breed and age 
association.  
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Horses suffering from laminitis and insulin resistance seem to have a slow recovery 
process, but recovery is more likely if insulin sensitivity is improved (Walsh et al. 2009). 
Increased exercise, maintaining optimal body condition, avoidance of high-glycaemic 
meals and molasses should be incorporated in the treatment of laminitis. Agents that 
improve insulin sensitivity could also become a part of the treatment of laminitis. Horses 
with insulin resistance have a higher risk of developing laminitis and to find and treat 
horses with insulin resistance would be a means of preventing laminitis. 
 
There is some evidence that pasture associated laminitis is one of the most common 
forms of laminitis (NAHMS 2005), and this is most likely associated with underlying 
endocrine dysfunction i.e. insulin resistance. Further, from extrapolation, it is possible 
that the majority of cases of laminitis not associated with severe systemic illness, severe 
trauma or exposure to Black Walnut are associated with insulin resistance. However, 
what the prevalence of insulin resistance in horses presented with laminitis is, that is 
currently unknown and it has not been studied previously. 
 
The purpose of the study was to determine the prevalence of insulin resistance in 
laminitic horses and ponies in Helsinki University Equine Clinic between April 2007 and 
October 2008. This kind of study has not - to our knowledge - previously been conducted. 
Cases of laminitis associated with systemic illness or trauma were excluded. Associations 
between endocrinopathic laminitis and sex, age, body condition score, breed, season, 
Obel grade, the presence of laminitic rings, cresty neck, and bulging supraorbital fat were 
studied in 50 horses.  
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2.2 Materials and Methods 
 
2.2.1 Study design and population 
 
This was a cross-sectional study and the study population consisted of 50 horses/ponies 
that were screened for insulin resistance between April 1st 2007 and October 1st 2008. All 
laminitic horses/ponies that were admitted (37) during this period were included in this 
material. All horses and ponies were admitted at the Helsinki University Equine Clinic as 
patients or for corrective shoeing. Breed, age and sex of the patients were recorded. 
Insulin was measured from all laminitic patients, patients with a high body condition 
score, patients undergoing prolonged corticosteroid treatment and patients suspected of 
having Equine Cushing’s disease. Inclusion criteria were testing for insulin resistance 
because of obesity, laminitis or endocrinopathy and laminitis. Exclusion criteria were 
insulin testing prior to or after a long course of corticosteroid treatment. The body 
condition of the horses was scored using the 0-5 graded Carroll & Huntington body 
condition scoring (Carroll & Huntington, 1988). Signs of Equine Metabolic Syndrome, 
bulging supraorbital fat, cresty necks and laminitic rings were recorded. When laminitis 
was diagnosed, X-ray findings and Obel grade of 0-5 (Obel N, 1948) were recorded.  
2.2.2 Laboratory examination 
 
Blood samples were collected in 6 ml serum sample tubes (Vacuette®, Greiner bio one, 2 
serum clot activator) using a vacutainer (Vacutainer®, Becton & Dickinson, Plymouth, 
United Kingdom). All horses were fasted at least an hour before taking the blood sample. 
The samples were centrifuged and the serum was separated within three hours, frozen to -
20 ?C and sent to Cambridge Specialist Laboratories by courier to arrive in seven days. 
The samples were analysed using the Pharmacia Insulin radioimmunoassay 1001 
validated for use in horses. A reference range of 5-30 ?IU/ml was used based on 
published ranges (McGowan et al. 2004, Ralston, 2002) and the type of assay used.  
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2.2.3 Definitions 
 
Insulin resistance was defined as a basal insulin level of over 30 ?IU/ml, based on 
published results (McGowan et al. 2004, Frank 2008). Horses with laminitis and insulin 
resistance were defined as having endocrinopathic laminitis. 
 
The 14 original breeds were categorized into four groups of breeds. The first group 
included 11 Warmblood (the warmblood group), the second included 13 riding ponies, 
one Connemara, one New forest, two Shetland ponies, one Welsh cob (the pony group). 
The third group included nine Finnhorses, three Norwegian fjord horses, three Icelandic 
horses and two Estonian draft horses (the coldblood and Icelandic horses group). Finally, 
the fourth group included one Arabian, one American Quarterhorse, one Standardbred 
and one mixed breed (the other breed group). 
 
The horses were divided into two groups, the nonobese group and the obese group, based 
on their body condition score. Horses with a body condition score higher than 3 were 
grouped as obese and horses with a body condition score of three or lower were grouped 
as non obese. Season of testing basal insulin value was obtained by categorizing the 
testing date into summer (1st of June-31st of August) and winter (1st of September-30th of 
May). To further determine any significant differences of Obel grade between the horses 
with and without endocrinopathic laminitis, the horses were divided into one group with 
mild lameness (Obel grade 0 or 1) and another group with severe lameness (Obel grade 2, 
3 or 4). 
 
2.2.4 Statistical methods 
 
All statistical analyses were performed using SPSS® 16.0 for Windows® (SPSS Inc, 
Chicago, IL, USA). For descriptive purposes the procedures Cross tabs, Frequency and 
Logistic regression were used. The 95% confidence intervals (95% CI) based on binomial 
distribution for obtained percentages (such as prevalence) were calculated using the 
approximation in Casella and Berger (1990), with continuity correction. Confidence 
intervals were calculated, because the horses/ponies included in the study were only a 
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sample of all possible horses/ponies that could have been included during the period (at 
another period or at another clinic the material would be different even if the same 
inclusion criteria were used). 
 
The age distribution between horses with endocrinopathic laminitis and horses without 
endocrinopathic laminitis was compared using the T-test procedure, because the age was 
normally distributed. 
 
The potential risk factors for endocrinopathic laminitis (Figure 2) were studied 
preliminary using the Cross Tabs procedure (with Pearson Chi-square testing) and 
univariable Logistic Regression procedure regressing endocrinopathic laminitis on the 
following variables: sex, body condition score, breed, season, Obel grade, the presence of 
laminitic rings, cresty neck and bulging supraorbital fat, one at a time. In the regression 
analyses the group of 32 horses with endocrinopathic laminitis and the group of 18 horses 
without laminitis were compared. The category of horses without endocrinopathic 
laminitis included horses with insulin resistance, but no laminitis (N=6), horses with 
laminitis, but no insulin resistance (N=4) and horses with neither complaint (N=8). The 
associations of the same variables with insulin resistance were similarly studied in the 37 
laminitic horses/ponies. 
 
Multivariable logistic regression analyses for endocrinopathic laminitis were not 
conducted, as all statistically significant (Wald p-value < 0.20) variables were 
interrelated. The relationship between the variables was studied with the Cross Tabs 
procedure. Body condition score was assumed to be a potential risk factor both for 
endocrinopathic laminitis (dependent variable) and the presence of bulging supraorbital 
fat (independent variable); being a potential confounder it was included in the logistic 
regression analyses with the bulging supraorbital fat. 
 
 
The prevalence of insulin resistance in the laminitic group was calculated. Basal insulin 
levels  increase  logarithmically  (Figure  3)  and  therefore  the  geometric  mean  was  
calculated for horses with endocrinopathic laminitis and horses without endocrinopathic 
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laminitis. The arithmetic mean of the logarithm transformed values of the basal insulin 
values (i.e. the arithmetic mean on the log scale) was computed and then it was returned 
to the original scale using the exponentiation (Cochran & Snedecor, 1989). The geometric 
mean is related to the log-normal distribution. 
 
If the odds ratios (OR) obtained from the logistic regression analyses were greater than 
one, the studied independent variable was considered as a potential risk factor; if OR was 
between zero and one, the studied independent variable was considered a potential 
protective factor. The ORs were transformed into ratios of probabilities using the fact that 
odds equals the probability of being diseased divided by the probability of being non-
diseased (as described for example in Toft et al. 2004): Odds = P/(100-P), where P = 
probability of disease given in %, and P = odds/(100+odds).  
 
The ORs cannot be interpreted as ratios of two probabilities (i.e. risk ratios), if the 
probability of the disease is greater than 5% (Dohoo et al. 2003). The OR is the odds of 
those exposed divided by the odds of those not exposed (OR = odds(exposed)/odds(not 
exposed)). First we assumed that the probability of disease in those not exposed was 50% 
giving odds(not exposed) = 1. Therefore, the ORs obtained could be considered 
representing odds(exposed), since odds(exposed)/1 = odds(exposed). Then we could 
calculate the probability of disease in exposed being odds(exposed)/(100+odds(exposed)). 
However, since we knew the probability of disease in the not exposed group was not 
50%, we calculated the appropriate probability of disease in the exposed group with the 
following formula derived from the previous formulas:  
 
Pexp=100*(Pexp50%*(100-Pnotexp50%)/(Pnotexp50%*(100-Pexp50%))*Pnotexp)/(100-Pnotexp*(1-(Pexp50%*(100-
Pnotexp50%)/(Pnotexp50%*(100-Pexp50%))))),  
where  
Pexp = actual probability of disease in exposed 
Pexp50%= probability of disease in exposed when the probability of disease in not exposed 
is 50% 
Pnotexp50%= 50% (set probability of disease in not exposed) 
Pnotexp = actual probability of disease in not exposed 
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Finally, the ratio of these probabilities was calculated as follows:  Pexp/ Pnotexp 
 
 
 
 
Figure 2. The potential risk factors for endocrinopathic laminitis as composed by author. 
 
 
 
 
 
 
 
 
2.3 Results 
 
All together 32 horses of the 50 horses studied had endocrinopathic laminitis of which 31 
had insulin resistance and laminitis. One horse had Equine Cushing's disease and 
Age 
Season 
Breed 
Sex 
BCS Supraorbital fat 
Diet 
Endocrinopathic laminitis 
Laminitic rings 
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laminitis but a normal basal insulin level. This horse was included in the group of horses 
with endocrinopathic laminitis. All results were checked without this horse and no 
important changes in the results were recognized.   
 
The material included 37 horses and ponies with laminitis. The prevalence of insulin 
resistance in these 37 laminitic horses/ponies was 84% (95% CI 69-92%: Table 1). As 
measured with 95% confidence intervals frequencies for laminitic rings, cresty neck, and 
bulging supraorbital fat were statistically almost significantly higher in the group with 
laminitis and insulin resistance than in the group with laminitis but no insulin resistance 
(Table 1). Frequencies of laminitic rings and bulging supraorbital fat were significantly 
higher at 95% confidence level in the group with endocrinopathic laminitis compared to 
the group without endocrinopathic laminitis (Table 2). 
 
The mean age of the endocrinopathic laminitis group was 16 years and that of the group 
without endocrinopathic laminitis was 13 years (Table 3), this difference was statistically 
significantly different (t-test p-value < 0.001). The mean age of all 50 horses was 
relatively high (15 years). The geometric mean basal insulin value of all the horses was 
53.47 ?IU/ml, the geometric mean basal insulin level of horses with endocrinopathic 
laminitis was 96.02 ?IU/ml (arithmetic distribution in Figure 4), and the geometric mean 
basal insulin level of horses without endocrinopathic laminitis was 18.92 ?IU/ml 
(arithmetic distribution in Figure 4). 
 
Horses/ponies with laminitic rings had 34.67 times higher odds of having endocrinopathic 
laminitis than horses without laminitic rings (Table 4, Wald p-value <0.001). This means 
that horses/ponies with laminitic rings were almost five (4.73) times more likely to have 
endocrinopathic laminitis than horses without laminitic rings. The association between 
obesity and endocrinopathic laminitis was almost statistically significant at 95% 
confidence level (p-value 0.069). Obel grade three was associated with endocrinopathic 
laminitis with a p-value of 0.045 (Wald) and when the horses were divided into two 
groups based on the Obel grade (mild and severe lameness), severe lameness was 
significantly correlated with endocrinopathic laminitis (Wald p-value 0.007).  
Horses/ponies with bulging supraorbital fat had 6.09 times higher odds of having 
 25
endocrinopathic laminitis than horses without bulging supraorbital fat (Table 4). This 
means that horses/ponies with bulging supraorbital fat were almost two (1.99) times more 
likely to have endocrinopathic laminitis than horses without bulging supraorbital fat. 
 
 
When studying the associations of these same independent variables with insulin 
resistance in the horses with laminitis (Table 5) the presence of a cresty neck was almost 
significantly associated with insulin resistance (Wald p-values 0.057). The presence of 
laminitic rings was significantly different between horses with insulin resistance and 
horses without insulin resistance (Wald p-value 0.019).  
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Table 1. Description of 37 laminitic horses/ponies in Helsinki University Equine Clinic 
between April 1st 2007 and October 1st 2008. Statistically almost significant differences 
between horses/ponies with or without insulin resistance are indicated with italics. 
 All laminitic horses Laminitic horses 
with insulin 
resistance  
Laminitic horses 
without 
insulinresistance  
n 37 31 6 
Factor % CI 95 % 1 % CI 95 %  % CI 95 %  
Gender:   
          Gelding 
              Mare 
 
48.6 
51.4 
 
33.4 - 64.06 
35.94 - 66.6 
 
48.4 
51.6 
 
31.98 - 65.17 
34.83 - 68.02 
 
50 
50 
 
18.76 - 81.24 
18.76 - 81.24 
Laminitic 
rings 
75.7 59.91 - 86.66 83.9 67.4 - 92.93 33.3 9.66 - 69.98 
Cresty neck 56.8 40.95 - 71.37 64.5 46.93 - 78.87 16.7 3.02 - 56.38 
Bulging 
suprarbital fat 
 
54.1 
 
38.43 - 69 
 
61.3 
 
43.83 - 76.28 
 
16.7 
 
3.02 - 56.38 
Breed: 
   Warmblood 
  Pony breeds 
   Draft breeds 
  Other breeds 
  
18.9 
37.8 
32.4 
10.8 
 
9.47 - 34.18 
24.03 - 53.86 
19.61 - 48.5 
4.28 - 24.7 
 
19.4 
38.7 
32.3 
9.7 
 
9.22 - 36.33 
23.72 - 56.17 
18.6 - 49.9 
3.36 - 24.93 
 
16.7 
33.3 
33.3 
16.7 
 
3.02 - 56.38 
9.66 - 69.98 
9.66 - 69.98 
3.02 - 56.38 
Season: 
         Summer 
           Winter 
 
32.4 
67.6 
 
19.61 - 48.5 
51.5 - 80.39 
 
32.3 
67.7 
 
18.6 - 49.9 
50.1 - 81.4 
 
33.3 
66.7 
 
9.66 - 69.98 
30.02 - 90.34 
Insulin 
resistance2 
 
83.8 
 
68.88 - 92.36 
 
100 
 
NA 
 
0 
 
NA 
Laminitis2 100 NA 100 NA 100 NA 
ECD3 29.7 17.47 - 45.75 32.3 18.6 - 49.9 16.7 3.02 - 56.38 
BCS4: 
                     2 
                     3 
                     4 
                     5 
  
2.7 
16.2 
54.1 
27 
 
0.48 - 13.82 
7.64 - 31.12 
35.94 - 66.6 
15.38 - 42.95 
 
 3.2 
12.9 
51.6 
32.3 
 
0.56 - 16.16 
5.13 - 28.85 
34.83 - 68.02 
18.6 - 49.9 
 
0 
33.3 
66.7 
0 
 
0 – 39.03 
9.66 - 69.98 
30.02 - 90.34 
0 – 39.03 
Obesity: 
            Obese 
      Nonobese 
 
81.1 
18.9 
 
65.82 – 90.53 
9.47 – 34.18 
 
83.9 
16.1 
 
67.4 – 92.93 
7.07 – 32.6 
 
66.7 
33.3 
 
30.02 - 90.34 
9.66 - 69.98 
Obel grade: 
                     0 
                     1 
                     2 
                     3 
                     4 
 
32.4 
18.9 
27 
16.2 
5.4 
 
19.61 - 48.5 
9.47 - 34.18 
15.38 - 42.95 
7.64 - 31.12 
1.49 - 17.7 
 
25.8 
19.4 
32.3 
16.1 
6.5 
 
13.7 - 43.24 
9.22 - 36.33 
18.6 - 49.9 
7.07 - 32.6 
1.81 - 20.78 
 
66.7 
16.7 
0 
16.7 
0 
 
30.02 - 90.34 
3.02 - 56.38 
0 – 39.03 
3.02 - 56.38 
0 – 39.03 
 
1CI 95 % = 95 % Confidence interval 
2 = Criteria for inclusion/exclusion of horses into the groups 
3ECD = Equine Cushing’s disease 
4BCS = Body condition score 
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Table 2. Description of 50 horses/ponies in Helsinki University Equine Clinic 
between April 1st 2007 and October 1st 2008. Statistically significant differences 
between horses/ponies with or without ECPL1 are indicated with italics. 
 All horses Horses with ECPL Horses without ECPL 
n 50 32 18 
Factor % CI 95 % 2 % CI 95 %  % CI 95 %  
Gender:  
               Gelding 
                   Mare 
 
52  
48  
 
38.51 - 65.2  
34.8 - 61.49 
 
46.9  
53.1  
 
30.89 - 63.57 
36.43 - 69.11 
 
61.1 
38.9 
 
38.61 – 79.69 
20.31 – 61.39 
Laminitic rings 56 42.31 - 68.84 81.2  64.63 -91.08 11.1 3.1 – 32.79 
Cresty neck 58  44.23 - 70.63 62.5  45.25 - 77.07 50 29.03 – 70.97 
Bulging 
suprarbital fat 
 
44  
 
31.16 - 57.69 
 
59.4  
 
42.28 - 74.5 
 
16.7 
 
5.85 – 39.26 
Breed: 
        Warmblood 
       Pony breeds 
        Draft breeds 
       Other breeds 
 
22  
36 
34  
8  
 
12.75 - 35.24 
24.14 - 49.86 
22.44 - 47.85 
3.15 - 18.84 
 
21.9  
37.5  
31.2  
9.4  
 
11.04 - 38.78 
22.93 - 54.75 
17.91 - 48.52 
3.25 - 24.25 
 
22.2 
33.3 
38.9 
5.6 
 
8.99 – 45.19 
16.26 – 56.22 
20.31 – 61.39 
1 – 25.82 
Season: 
              Summer 
                Winter 
 
32  
68  
 
20.76 - 45.81 
54.19 - 79.24 
 
31.2  
68.0  
 
17.91 - 48.52 
54.19 - 79.24 
 
33.3 
66.7 
 
16.26 – 56.22 
43.78 – 83.74 
Insulin 
resistance3 
72  58.33 - 82.3 96.9  84.29 - 99.45 27.8 12.51 – 50.9 
Laminitis3 74  60.45 - 84.13 100  NA 27.8 12.51 – 50.9 
Equine Cushing's 
disease 
 
30 
 
19.1 - 43.75 
 
34.4  
 
20.43 - 51.71 
 
22.2 
 
8.99 – 45.19 
BCS4: 
                          2 
                          3 
                          4 
                          5 
 
2  
22  
46  
30  
 
0.35 - 10.5 
12.75 - 35.24 
32.97 - 59.6 
19.1 - 43.75 
 
3.1  
12.5  
53.1  
32.1  
 
0.55 - 15.71 
4.97 - 28.07 
36.43 - 69.11 
18.61 - 49.42 
 
0 
38.9 
33.3 
27.8 
 
0 – 17.59 
20.31 – 61.39 
16.26 – 56.22 
12.51 – 50.9 
Obesity: 
                  Obese 
            Nonobese 
 
76 
24 
 
62.59 – 85.7 
14.3 – 37.41 
 
84.4 
15.6 
 
68.27 – 93.15 
6.85 – 31.73 
 
61.1 
38.9 
 
38.61 – 79.69 
20.31 – 61.39 
Obel grade: 
                          0 
                          1 
                          2 
                          3 
                          4 
 
50  
14 
20  
12 
4 
 
36.64 - 63.36 
6.95 - 26.19 
11.24 - 33.04 
5.62 - 23.81 
1.1 -13.46 
 
25 
21.9  
31.2 
15.6  
6.2  
 
13.25 - 42.11 
11.04 - 38.78 
17.91 - 48.52 
6.85 - 31.73 
1.71 - 20.08 
 
94.4 
0 
0 
5.6 
0 
 
74.18 – 99 
0 – 17.59 
0 – 17.59 
1 – 25.82 
0 – 17.59 
 
1ECPL = Endocrinopathic laminitis 
2CI 95 % = 95 % Confidence interval 
3 Criteria for inclusion/exclusion of horses into the groups 
4BCS = Body condition score 
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Table 3. Results of basal insulin level and age distribution in 50 
horse/ponies in Helsinki University Equine Clinic between April 1st 2007 
and October 1st 2008. 
 All ECPL1 (n2 = 32) Non ECPL (n = 18) 
Age (yrs): 
                    Mean 
                 Median 
             Minimum 
            Maximum 
 
15 
15 
7 
27  
 
16 
15 
7 
27 
 
13 
13 
7 
20 
Insulin results 
??IU/ml): 
  Geometric mean 
                 Median 
             Minimum 
            Maximum 
 
 
53.47 
47 
3 
600 
 
 
96.02 
98.5 
15 
600 
 
 
18.92 
21.25 
3 
54 
 
1 ECPL = Endocrinopathic laminitis 
2n = number of horses 
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Table 4. Results of nine univariable and one bivariable logistic regression analyses for 
endocrinopathic laminitis in 50 horse/ponies in Helsinki University Equine Clinic 
between April 1st 2007 and October 1st 2008. 
Risk factor b1 p-value 
(Wald) 
OR2 CI 95 %3 
Gender: 
                      Mare* 4 
                      Gelding 
 
NA5 
0.577 
 
1 
0,336 
 
0 
1.781 
 
NA 
0.550 – 5.766 
Breed: 
              Warmblood* 
               Pony breeds 
               Draft breeds 
              Other breeds 
 
NA 
0.134 
-0.203 
0.539 
 
1 
0,868 
0,799 
0,682 
 
0 
1.143 
0.816 
1.714 
 
NA 
0.237 – 5.501 
0.171 – 3.895 
0.131 – 22.513 
Season 
                   Summer* 
                        Winter 
 
NA 
0.095 
 
1 
0.880 
 
0 
1.100 
 
NA 
0.321 – 3.773 
Cresty neck 0.511 0.392 1.667 0.518 – 5.363 
Laminitic rings 3.546 0.000 34.667 6.225 – 193.58 
BCS6: 
                               2* 
                                 3 
                                 4 
                                 5 
 
NA 
-21.763 
-20.161 
-20.510 
 
1 
1.000 
1.000 
1.000 
 
0 
0.000 
0.000 
0.000 
 
NA 
Obesity: 
                 Nonobese* 
                         Obese  
 
NA 
1.234 
 
1 
0.069 
 
0 
3.436 
 
NA 
0.895 – 13.187 
Obel grade 
                              0 * 
                                 1 
                                 2 
                                 3 
                                 4 
 
NA 
21.957 
21.957 
2.363 
21.957 
 
1 
0.999 
0.999 
0.045 
0.999 
 
0 
3.433E9 
3.433E9 
10.625 
3.433E9 
 
NA 
0 
0 
1.059 – 106.573 
0 
Lameness 
                            mild 
                         severe 
 
NA 
2.958 
 
1 
0.007 
 
0 
19.297 
 
NA 
2.283 – 162.606 
Bulging supraorbital 
fat (when controlled 
for BCS)7   
 
1.807 
(0.547) 
 
0.019 
(0.467) 
 
6.094 
(1.727) 
 
1.353 – 27.436 
(0.395 – 7.547) 
 
1b = Regression coefficient 
2OR = Odds ratio 
3CI 95 % = 95 % Confidence interval of odds ratio 
4* = Reference group  
5NA = Not applicable 
6BCS = Body condition score  
7Coefficient, p-value and odds ratio for BCS in brackets; BCS had here two categories 
similar to obesity 
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Table 5. Results of eight univariable and one bivariable logistic regression analyses for 
insulin resistance in 37 laminitic horse/ponies in Helsinki University Equine Clinic 
between April 1st 2007 and October 1st 2008. 
Risk factor b1 p-value 
(Wald) 
OR2 CI 95 %3 
Gender: 
                  Gelding*4  
                          Mare 
 
NA5 
0.065 
 
1 
0.942 
 
0 
1.067 
 
NA 
0.186 – 6.129 
Breed: 
             Warmblood* 
              Pony breeds 
              Draft breeds 
              Other breeds 
 
NA 
0.000 
-0.182 
-0.693 
 
1 
1.000 
0.891 
0.661 
 
0 
1.000 
0.833 
0.500 
 
NA 
0.75 – 13.367 
0.062 – 11.277 
0.023 – 11.088 
Season: 
                   Summer* 
                       Winter 
 
NA 
0.049 
 
1 
0.959 
 
0 
1.050 
 
NA 
0.164 – 6.724 
Cresty neck 2.207 0.057 9.091 0.940 - 87.959 
Laminitic rings 2.342 0.019 10.400 1.482 – 72.998 
BCS: 
                              2* 
                                3 
                                4 
                                5 
 
NA 
-20.510 
-19.817 
0.000 
 
1 
1 
1 
1 
 
0 
0 
0 
1 
 
NA 
0 
0 
0 
Obesity: 
                Nonobese* 
                        Obese  
 
NA 
0.956 
 
1 
0.337 
 
0 
2.6 
 
NA 
0.370 - 18.249 
Obel grade 
                                0 
                                1 
                                2 
                                3 
                                4 
 
NA 
1.099 
20.510 
0.916 
20.510 
 
0.9 
0.376 
0.999 
0.465 
0.258 
 
0 
3 
8.077E8 
2.5 
8.077E8 
 
NA 
0.263 - 34.198 
0 
0.214 - 29.254 
0 
Bulging supraorbital 
fat (when controlled 
for BCS)7 
 
2.003 
(0.214) 
 
0.096 
(0.841) 
 
7.411 
(1.239) 
 
0.701 - 78.390 
(0.153 - 10.049) 
 
1b = Regression coefficient 
2OR = Odds ratio 
3CI 95 % = 95 % Confidence interval of odds ratio 
4* = Reference group  
5NA = Not applicable 
6BCS = Body condition score 
7Coefficient, p-value and odds ratio for BCS in brackets; BCS had here two categories 
similar to obesity 
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A. B. 
   
Figure 3. Arithmetic insulin results (A) and logarithmic insulin results (B) of 50 horses admitted to 
Helsinki University Equine Clinic between April 1st 2007 and October 1st 2008. 
 
 
A. B. 
  
Figure 4. Arithmetic insulin results of 32 horses with endocrinopathic laminitis (A) and 18 horses 
without endocrinopathic laminitis (B) at Helsinki University Equine Clinic between April 1st 2007 
and October 1st 2008. 
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2.4 Discussion 
 
The high prevalence of insulin resistance in the laminitic horses in Helsinki University 
Equine Clinic (between April 1st 2007 and October 1st 2008) shows that it is an important 
feature to acknowledge. However, with this material the result tells us nothing about the 
prevalence of insulin resistance in laminitic horses in Finland in general. As the material 
was collected from a referral hospital and a farrier, it could be assumed that there was a 
higher degree of cases with chronic and complicated laminitis. This would give a higher 
prevalence than in general, because insulin resistance is associated with a poorer 
prognosis and complications of laminitis. The result implies that a high proportion of the 
horses admitted to the clinic because of laminitis also have insulin resistance.  
 
No significant differences in the distribution of sex, season, Obel grade or obesity 
between insulin resistant horses and the horses without insulin resistance were found in 
the group of laminitic horses. The presence of laminitic rings, cresty neck and bulging 
supraorbital fat had Wald p-values of 0.019, 0.06 and 0.096, respectively. The lack of 
significance at 95% confidence level of the two last variables is probably due to the small 
amount of laminitic horses that did not have insulin resistance. 
 
One horse had laminitis and equine Cushing’s disease but a normal basal insulin level. 
This horse was grouped as having endocrinopathic laminitis, as it may have had stable 
insulin but chronic hoof changes from previous high insulin. The insulin result could also 
have been lower for some reason e.g. he may have been fasted on his way to the hospital.  
The statistics were done with and without this individual to ensure it did not alter any 
results. 
 
No significant differences in the distribution of sex, breed, season, Obel grade, body 
condition score or the presence of cresty neck between endocrinopathic and 
nonendocrinopathic horses were found (Table 4).  
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Previous studies have shown a breed predilection for both laminitis and insulin resistance, 
with pony breeds being prone to both insulin resistance and laminitis (Treiber, Kronfeld, 
Hess et al. 2006, Alford et al. 2001). The result in this study is propably due to the fact 
that there were no matched controls in this study. 
 
Mares have been shown to have a higher risk to develop laminitis than geldings, but 
insulin resistance has not been shown to have a sex predilection, although physiologic 
insulin resistance occurs during pregnancy and lactation (Alford et al. 2001, Fowdean et 
al. 1984). In this study the gender was not a risk factor for endocrinopathic laminitis or 
insulin resistance in laminitic horses. 
 
The presumption was that seasonality would affect the occurrence of endocrinopathic 
laminitis. Laminitis occurs more often during the summer, when horses are out on pasture 
and a diet high in starch, such as lush pasture, decreases insulin sensitivity. The even 
distribution of cases between summer and winter months could be due to relapses of the 
disease. Some horses in the endocrinopathic laminitis group did not suffer from laminitis 
at the time of blood sampling, but had chronic changes in the hooves. 
 
The age distribution was higher in horses with endocrinopathic laminitis than in horses 
without endocrinopathic laminitis. The incidence of chronic laminitis is higher in older 
horses and also the incidence of ECD increases with age (Polzer et al.1996, van der Kolk 
et al.1993). Whether the age affects the incidence of insulin resistance is not known, 
although there seem to be some age influence on insulin sensitivity in the horses (Murpy 
et al. 1997). In this study the high mean age of the material in general may have had an 
influence on the result.  
 
A high Obel grade (2-4) was significantly correlated with endocrinopathic laminitis in 
this material (Table 4, severe lameness). Previous reports have shown significant 
correlation between plasma insulin and laminitis grade (Walsh et al. 2008).  
 
The body condition score was not significantly associated with endocrinopathic laminitis. 
However, the association between obesity (horses/ponies with body condition score 
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above 3 were considered as obese) and endocrinopathic laminitis almost reached 
statistical significance at 95% confidence level. Despite the nonsignificance at this level, 
this result can be seen as being consistent with the results of previous studies. Some 
horses were tested only because they were obese and this increased the amount of obese 
horses in the nonlaminitic group. In a case-control study the difference in obesity between 
horses with endocrinopathic laminitis and horses without it would probably be greater. 
 
In a study by Frank et al. (2006) the neck circumference was significantly correlated with 
area under curve for insulin. Their conclusion was that measurements of neck 
circumference should be taken, in addition to body condition score and insulin to identify 
horses at risk for insulin resistance. In this study no significant correlation between 
endocrinopathic laminitis and a cresty neck was found. However, the correlation between 
insulin resistance and cresty neck was almost statistically significant (Wald p-value 0.06). 
The neck circumference was not measured in this study. The horses were subjectively 
evaluated by the treating veterinarian as having or not having a cresty neck. The reason 
for this difference in results is most likely the same as for the lack of correlation between 
endocrinopathic laminitis and a high body condition score, i.e. the screening of some 
obese, but otherwise healthy horses for insulin resistance. 
 
The horses with bulging supraorbital fat were approximately two times more likely to 
also have endocrinopathic laminitis. This association has been reported previously and it 
is one of the features of equine metabolic syndrome (Johnson, 2002). 
 
Horses  with  laminitic  rings  were  almost  five  times  more  likely  to  also  have  
endocrinopathic laminitis. Partially this is self-evident, as horses without laminitis would 
not have laminitic rings and most of the laminitic horses were included in the group of 
endocrinopathic laminitis. The association could also be due to the chronic nature of 
endocrinopathic laminitis, as laminitic rings are a sign of chronic changes in the hoof. 
Because of the lack of information for some horses the distribution between acute and 
chronic laminitis between the groups could not be calculated.  
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In this study only basal insulin was measured of the horses and it is not the most accurate 
method of diagnosing insulin resistance. This means that some cases of insulin resistance 
could have been missed, either because the laminitis had been caused by a previous 
period of high insulin or the insulin was momentarily lower for some reason (fasting for 
example). Horses with laminitis but a normal basal insulin value were included in the 
group of horses with nonendocrinopathic laminitis and the laminitic horses were divided 
into insulin resistant and non insulin resistant based on their basal insulin value. This 
could mean that some horses might have been grouped into a wrong group. 
 
The results in this study were obtained using several univariable logistic regression 
analyses (except with bulging supraorbital fat) and therefore possible confounding effects 
of other variables have not been taken into account.  
 
Due to the cross sectional study design it was not possible to conclude the time sequence, 
i.e. whether the variables (bulging supraorbital fat and laminitic rings) precedes the 
disease or are caused by the disease. However, the correlation justifies including the 
presence of laminitic rings and bulging supraorbital fat as a phenotypic indicators of 
endocrinopathic laminitis and the equine metabolic syndrome. 
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2.5 Conclusions 
 
1. The prevalence of insulin resistance in the 37 laminitic horses at Helsinki University 
Equine Clinic between April 1st 2007 and October 1st 2008 was 84%, so the majority of 
admitted laminitic horses were insulin resistant. 
 
2. The horses with bulging supraorbital fat were approximately two times more likely to 
also have endocrinopathic laminitis and horses with laminitic rings were almost five 
times more likely to also have endocrinopathic laminitis in this material. Severe lameness 
was significantly correlated with endocrinopathic laminitis. 
 
3. The mean age of horses with endocrinopathic laminitis was significantly higher than 
the mean age of horses without endocrinopathic laminitis. 
 
4. There was a statistically almost significant difference at 95% confidence level in the 
distribution of cresty neck and bulging supraorbital fat between the groups (Wald p-
values 0.06 and 0.096, respectively). Laminitic rings were statistically more frequent in 
horses with insulin resistance and laminitis than horses with laminitis and normal insulin 
level (Wald p-value 0.019). 
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